# The role of sugar transport in C. difficile colonization and disease

> **NIH NIH P20** · UNIVERSITY OF LOUISVILLE · 2022 · $295,325

## Abstract

Clostridioides difficile infection (CDI) is still the most common cause of healthcare-associated infection despite a concerted effort to reduce the incidence. Increasingly, C. difficile is found in the community among persons with no recent healthcare contact. The long-term goal of this project is to identify novel therapeutic targets which can be exploited to treat CDI and control the spread of C. difficile. The overall objectives in this application are to (i) elucidate the specificity and redundancy of the sugar transporters under positive selection in C. difficile, (ii) determine their role in disease, and iii) examine the impact of dietary sugar on asymptomatic carriage. The central hypothesis is that C. difficile has evolved to better occupy niche space within the gastrointestinal tract (GIT) by taking advantage of the modem sugar-rich diet. The rationale for this project is that determining the specificity and importance of sugar transporters and downstream metabolism in C. difficile carriage and infection sets up a robust scientific framework whereby new prophylaxis and treatment strategies can be developed. The central hypothesis will be tested by pursuing three specific aims: 1) Elucidate the specificity, redundancy, and influence on toxin production of evolving sugar transport genes, 2) Determine the effect of evolving sugar transport genes on community invasion and disease, and 3) Investigate the role of sugars in niche establishment and asymptomatic carriage. The research proposed in this application is innovative, because it focuses on the metabolic adaptation of C. difficile to carbohydrates and their role in asymptomatic carriage as well as disease. This focus has the potential to lead to novel prophylactic strategies that can be used against C. difficile before the emergence of the disease. The proposed research is significant as it will provide a solid scientific justification for the continued examination of metabolism as a virulence mechanism in C. difficile and provide a framework for the future study of novel prophylactic, intervention, and treatment options.

## Key facts

- **NIH application ID:** 10556877
- **Project number:** 5P20GM125504-05
- **Recipient organization:** UNIVERSITY OF LOUISVILLE
- **Principal Investigator:** James Tristan Collins
- **Activity code:** P20 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $295,325
- **Award type:** 5
- **Project period:** 2022-03-01 → 2023-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10556877

## Citation

> US National Institutes of Health, RePORTER application 10556877, The role of sugar transport in C. difficile colonization and disease (5P20GM125504-05). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10556877. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*